Lipoic Acid Ligase Protein Labeling Specificity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for labeling proteins inside cells lack specificity and often interfere with protein function due to the large size and limitations of existing biophysical probes, such as GFP and its variants, leading to poor specificity and cell toxicity.
Innovation Solution
The use of lipoic acid ligase and its mutants to site-specifically attach small molecules to proteins via acceptor polypeptides, allowing for precise labeling of proteins with lipoic acid analogs, including alkyl azides, aryl azides, and fluorophores, which are recognized by the ligase and do not perturb protein function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If GFP or GFP variants are used for protein labeling, then labeling specificity is improved, but protein function is perturbed due to large size
Solution Approach 1:
The invention segments the labeling system into three separate components: a small peptide tag (acceptor polypeptide) fused to the target protein, a lipoic acid ligase enzyme, and a lipoic acid analog probe. This segmentation allows each component to be optimized independently - the peptide tag is kept minimal (5-15 amino acids) to minimize functional perturbation, while the enzyme and probe can be designed for high specificity without adding bulk to the target protein.
Solution Approach 2:
The invention introduces an intermediary peptide tag sequence that serves as a recognition substrate for the lipoic acid ligase. This intermediary element enables specific labeling without requiring direct attachment of large probes to the target protein, thus maintaining protein function while achieving high labeling specificity through the enzyme-substrate interaction.
2Measurement precision
If protein-based targeting sequences are used (SNAP/AGT, Halotag, DHFR, FKBP), then labeling specificity is improved, but steric interference with receptor function occurs
Solution Approach 1:
The invention extracts the targeting function from large protein-based sequences and reduces it to a minimal peptide tag (5-15 amino acids). By taking out only the essential recognition elements and discarding the bulk of the protein-based targeting sequences, the system achieves high specificity while minimizing steric interference with the target protein's function.
3Ease of operation
If peptide-based targeting methods (FlAsH, His6-tag) are used, then labeling is simplified, but probe dissociation occurs
Solution Approach 1:
The invention replaces non-covalent binding mechanisms (which are prone to dissociation) with a covalent ligation reaction catalyzed by the lipoic acid ligase. The enzyme forms a stable covalent bond between the lipoic acid analog probe and the peptide tag, eliminating probe dissociation while maintaining the simplicity of peptide-based targeting.
4Measurement precision
If keto/biotin ligase or transglutaminase labeling is used, then labeling specificity is improved, but labeling is restricted to cell surface
Solution Approach 1:
The invention creates a universal labeling system where the lipoic acid ligase and lipoic acid analog can label proteins anywhere in the cell. The peptide tag can be fused to any protein of interest, and the enzymatic ligation can occur in the cytoplasm, nucleus, or on cell surfaces, providing multi-location versatility while maintaining high specificity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides high specificity and reduced cell toxicity, enabling precise labeling of proteins in vivo and in vitro, allowing for the tracking and imaging of proteins without interfering with their function.
Implementation Method 1
contacting a fusion protein with a lipoic acid analog, and allowing sufficient time for the lipoic acid analog to be conjugated to the fusion protein via an acceptor polypeptide, in the presence of a lipoic acid ligase or mutant thereof
Data Source
AI summary
The invention provides compositions and methods of use thereof for labeling peptide and proteins in vitro or in vivo. The methods described herein employ lipoic acid ligase or mutants thereof, and lipoic acid analogs recognized by lipoic acid ligase and lipoic acid ligase mutants.